NASDAQ
18.06.26 | 22:00
38,370 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Here's Why Momentum in Electromed (ELMD) Should Keep going | 1 | Zacks | ||
| 03.06. | Is Electromed (ELMD) a Solid Growth Stock? 3 Reasons to Think "Yes" | 2 | Zacks | ||
| 01.06. | Here's What Could Help Electromed (ELMD) Maintain Its Recent Price Strength | 2 | Zacks | ||
| 19.05. | Electromed, Inc. (ELMD)'s Technical Outlook is Bright After Key Golden Cross | 1 | Zacks | ||
| 18.05. | Electromed (ELMD) is an Incredible Growth Stock: 3 Reasons Why | 1 | Zacks | ||
| ELECTROMED Aktie jetzt für 0€ handeln | |||||
| 13.05. | Electromed outlines plan to add 4-5 sales reps next year as Smart Order adoption reaches 40% of orders | 4 | Seeking Alpha | ||
| 12.05. | Electromed Reports Q3 2026 Results: Full Earnings Call Transcript | 1 | Benzinga.com | ||
| 12.05. | Electromed Inc. Reports Climb In Q3 Income | 1 | RTTNews | ||
| 12.05. | Electromed GAAP EPS of $0.35 beats by $0.10, revenue of $18.6M beats by $1M | 1 | Seeking Alpha | ||
| 12.05. | Electromed, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 12.05. | Electromed, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.03. | Electromed (ELMD) Reports 13th Consecutive Quarter of Revenue and Profit Growth | 1 | Insider Monkey | ||
| 11.02. | Electromed signals continued double-digit revenue growth with 13th straight quarterly gains, highlighting expansion in bronchiectasis market | 1 | Seeking Alpha | ||
| 10.02. | Electromed GAAP EPS of $0.32 beats by $0.06, revenue of $18.9M beats by $0.85M | 1 | Seeking Alpha | ||
| 10.02. | Electromed, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 10.02. | Electromed, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.02. | What's Next: Electromed's Earnings Preview | 1 | Benzinga.com | ||
| 20.11.25 | Noble Financial Group, Inc.: Electromed, Inc. to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference | 483 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced... ► Artikel lesen | |
| 13.10.25 | Electromed, Inc. to Participate in LD Micro Main Event XIX | 474 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CO-DIAGNOSTICS | 3,310 | -1,78 % | Co-Diagnostics hosts Saudi joint venture for manufacturing tour | ||
| CYTOSORBENTS | 0,396 | +3,66 % | Cytosorbents Corp: CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | PRINCETON, N.J., May 13, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 4,310 | -1,15 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| IMUNON | 1,620 | -1,22 % | Imunon, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| FULGENT GENETICS | 15,600 | +1,96 % | Fulgent reports interim data for cancer drug FID-007 trial | ||
| CAREDX | 22,600 | 0,00 % | CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? | ||
| EMBECTA | 2,680 | -0,92 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| CHECK-CAP | 1,200 | +5,26 % | Humanoid Global gibt strategische Investition in MBody AI, Entwickler einer Autonomieplattform für verkörperte KI bekannt | - NICHT ZUR VERBREITUNG IN DEN VEREINIGTEN STAATEN ODER ÜBER US-NACHRICHTENDIENSTE BESTIMMT -
Vancouver, BC und Las Vegas, Nevada - 7. Januar 2026 / IRW-Press / Humanoid Global
... ► Artikel lesen | |
| ELECTROCORE | 7,150 | +2,88 % | electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes | Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness... ► Artikel lesen | |
| CATHETER PRECISION | 0,820 | 0,00 % | Catheter Precision, Inc.: Flyte Expands Strategic Relationship With Volato By Joining Vaunt Platform | Flyte Gains Access to Fast-Growing Private Aviation Membership Network While Unlocking New Revenue Opportunities across Its Cirrus Vision Jet Fleet Creates Additional Distribution Channel for Flyte... ► Artikel lesen | |
| CLEARPOINT NEURO | 17,780 | +0,06 % | ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains? | ||
| FIREFLY NEUROSCIENCE | 1,370 | 0,00 % | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| ENVUE MEDICAL | 0,681 | +1,34 % | ENvue Medical, Inc.: ENvue Medical Expands into Burn Intensive Care Unit at Major Academic Health Network | TYLER, Texas, June 05, 2026 (GLOBE NEWSWIRE) -- ENvue Medical (NASDAQ: FEED) ("ENvue," "ENvue Medical," or the "Company"), a commercial-stage medical device company focused on real-time guided bedside... ► Artikel lesen | |
| EXAGEN | 4,000 | +1,01 % | Exagen Inc. Reports First Quarter 2026 Results | CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended March 31, 2026... ► Artikel lesen | |
| ENDRA LIFE SCIENCES | 4,880 | +2,52 % | Endra Raises $50 Million Series A To Build AI-Based Infrastructure Platform For MEP Engineering Firms |
Das Unternehmen ELECTROMED INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 38,370 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELECTROMED INC finden Sie auf Wallstreet Online.